Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

Europe - AMS:CCEP - GB00BDCPN049 - Common Stock

80.45 EUR
+0.25 (+0.31%)
Last: 11/12/2025, 10:11:09 AM
Fundamental Rating

3

Overall CCEP gets a fundamental rating of 3 out of 10. We evaluated CCEP against 25 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. While showing a medium growth rate, CCEP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
CCEP had positive earnings in each of the past 5 years.
Each year in the past 5 years CCEP had a positive operating cash flow.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP has a better Return On Assets (4.83%) than 76.00% of its industry peers.
Looking at the Return On Equity, with a value of 19.11%, CCEP is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CCEP's Return On Invested Capital of 7.78% is fine compared to the rest of the industry. CCEP outperforms 64.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCEP is in line with the industry average of 8.01%.
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROIC 7.78%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP has a Profit Margin (7.35%) which is comparable to the rest of the industry.
CCEP's Profit Margin has declined in the last couple of years.
CCEP has a worse Operating Margin (11.13%) than 68.00% of its industry peers.
In the last couple of years the Operating Margin of CCEP has declined.
CCEP has a worse Gross Margin (35.20%) than 84.00% of its industry peers.
CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
CCEP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCEP has more shares outstanding
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.08 indicates that CCEP is not a great score, but indicates only limited risk for bankruptcy at the moment.
CCEP has a Altman-Z score (2.08) which is in line with its industry peers.
The Debt to FCF ratio of CCEP is 6.04, which is on the high side as it means it would take CCEP, 6.04 years of fcf income to pay off all of its debts.
CCEP's Debt to FCF ratio of 6.04 is fine compared to the rest of the industry. CCEP outperforms 80.00% of its industry peers.
CCEP has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
CCEP has a worse Debt to Equity ratio (1.26) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Altman-Z 2.08
ROIC/WACC1.04
WACC7.5%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.83 indicates that CCEP may have some problems paying its short term obligations.
CCEP has a worse Current ratio (0.83) than 76.00% of its industry peers.
CCEP has a Quick Ratio of 0.83. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.65, CCEP is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.83
Quick Ratio 0.65
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CCEP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.76%.
The Earnings Per Share has been growing slightly by 5.80% on average over the past years.
CCEP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.04%.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%

3.2 Future

CCEP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.82% yearly.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.75% yearly.
EPS Next Y4.31%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
EPS Next 5Y9.82%
Revenue Next Year2.1%
Revenue Next 2Y2.44%
Revenue Next 3Y2.93%
Revenue Next 5Y3.75%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.16, which indicates a rather expensive current valuation of CCEP.
CCEP's Price/Earnings ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 76.00% of the companies in the same industry.
CCEP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.35.
Based on the Price/Forward Earnings ratio of 17.71, the valuation of CCEP can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CCEP is valued a bit more expensive than 64.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 33.72. CCEP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.16
Fwd PE 17.71
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCEP indicates a slightly more expensive valuation: CCEP is more expensive than 72.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 18.37
EV/EBITDA 13.65
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.61
PEG (5Y)4.16
EPS Next 2Y6.48%
EPS Next 3Y7.12%

3

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.62%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.20, CCEP is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, CCEP has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.62%

5.2 History

On average, the dividend of CCEP grows each year by 9.91%, which is quite nice.
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

CCEP pays out 60.89% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP60.89%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (11/12/2025, 10:11:09 AM)

80.45

+0.25 (+0.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-05 2025-11-05
Earnings (Next)N/A N/A
Inst Owners37.34%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap36.52B
Revenue(TTM)20.88B
Net Income(TTM)1.53B
Analysts77.27
Price Target87.77 (9.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.62%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP60.89%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.16%
PT rev (3m)-0.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.1%
EPS NY rev (3m)-1.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 24.16
Fwd PE 17.71
P/S 1.75
P/FCF 18.37
P/OCF 12.49
P/B 4.55
P/tB N/A
EV/EBITDA 13.65
EPS(TTM)3.33
EY4.14%
EPS(NY)4.54
Fwd EY5.65%
FCF(TTM)4.38
FCFY5.44%
OCF(TTM)6.44
OCFY8.01%
SpS46
BVpS17.68
TBVpS-19.71
PEG (NY)5.61
PEG (5Y)4.16
Graham Number36.4
Profitability
Industry RankSector Rank
ROA 4.83%
ROE 19.11%
ROCE 10.52%
ROIC 7.78%
ROICexc 8.57%
ROICexgc 51.16%
OM 11.13%
PM (TTM) 7.35%
GM 35.2%
FCFM 9.52%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexgc growth 3Y8.99%
ROICexgc growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF 6.04
Debt/EBITDA 3.08
Cap/Depr 98.22%
Cap/Sales 4.49%
Interest Coverage 9.37
Cash Conversion 89.23%
Profit Quality 129.6%
Current Ratio 0.83
Quick Ratio 0.65
Altman-Z 2.08
F-Score6
WACC7.5%
ROIC/WACC1.04
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%14.98%
EPS Next Y4.31%
EPS Next 2Y6.48%
EPS Next 3Y7.12%
EPS Next 5Y9.82%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%4.54%
Revenue Next Year2.1%
Revenue Next 2Y2.44%
Revenue Next 3Y2.93%
Revenue Next 5Y3.75%
EBIT growth 1Y2.97%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.74%
EBIT Next 3Y17.22%
EBIT Next 5Y13.31%
FCF growth 1Y5.8%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y13.11%
OCF growth 3Y13.08%
OCF growth 5Y9.96%

COCA-COLA EUROPACIFIC PARTNE / CCEP.AS FAQ

Can you provide the ChartMill fundamental rating for COCA-COLA EUROPACIFIC PARTNE?

ChartMill assigns a fundamental rating of 3 / 10 to CCEP.AS.


Can you provide the valuation status for COCA-COLA EUROPACIFIC PARTNE?

ChartMill assigns a valuation rating of 1 / 10 to COCA-COLA EUROPACIFIC PARTNE (CCEP.AS). This can be considered as Overvalued.


How profitable is COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) stock?

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for CCEP stock?

The Price/Earnings (PE) ratio for COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) is 24.16 and the Price/Book (PB) ratio is 4.55.


What is the earnings growth outlook for COCA-COLA EUROPACIFIC PARTNE?

The Earnings per Share (EPS) of COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) is expected to grow by 4.31% in the next year.